human-derived microbes

C. diff. is an urgent public health issue

Prevention of recurrence may require restoration of the gut microbiome

Learn More

microbial product

Developing a new class of biologic drugs for the treatment of debilitating diseases

Learn More

healthy gut microbiota

Restoring the microbiome may provide therapies for challenging medical problems

New therapies beyond antibiotics are urgently needed

Learn More

Harnessing the Power of the Microbiome to Revolutionize Treatment of Disease

Rebiotix Inc. is a clinical stage biotechnology company founded to revolutionize the treatment of debilitating diseases by harnessing the power of the human microbiome.

It is increasingly recognized that restoration of a healthy gut microbiota is necessary for the effective treatment of a large number of challenging diseases.

The Leader in Developing Microbiota-Based Therapies through the MRT™ Drug Platform

The MRT platform is our science for delivering live, human-derived microbes into a sick patient’s intestinal tract to treat disease.

We have the most advanced human clinical program evaluating a microbiota-based drug conducted in coordination with a regulatory authority. Our research encompasses studies with acute and chronic disease states, from both Rebiotix- and physician-sponsored studies. Check out our clinical program for more information.

Follow @Rebiotix

Looking forward to #ASMIcrobe2019 in #SanFrancsisco! Check out the events calendar here (and let us know if you'll be attending too)! tinyurl.com/yxalnqeb